Related Experiment Video
Updated: Jun 20, 2026
09:28
Process Optimization using High Throughput Automated Micro-Bioreactors in Chinese Hamster Ovary Cell Cultivation
Published on: May 18, 2020
Rational design of improved pharmabiotics
1Alimentary Pharmabiotic Centre, University College Cork, Ireland. roy.sleator@cit.ie
Journal of Biomedicine & Biotechnology
|September 16, 2009
Summary
This review explores advances in probiotic research, introducing patho-biotechnology. This novel approach uses pathogen stress survival strategies to create more robust probiotic cultures for enhanced applications.
Area of Science:
- Microbiology
- Biotechnology
- Probiotic Research
Background:
- Probiotics offer health benefits but often lack robustness.
- Current probiotic applications face limitations in stability and efficacy.
Purpose of the Study:
- To review recent advances in probiotic research.
- To introduce and explore the concept of patho-biotechnology.
- To highlight its potential for improving probiotic cultures.
Main Methods:
- Review of current scientific literature on probiotics.
- Analysis of pathogen stress survival mechanisms.
- Conceptual framework for applying these mechanisms to probiotics.
Main Results:
- Patho-biotechnology offers a novel strategy for probiotic development.
- Utilizing pathogen stress survival can enhance probiotic robustness.
- This approach promises improved biotechnological and clinical applications.
Conclusions:
- Patho-biotechnology represents a significant advancement in probiotic design.
- Enhanced probiotic cultures can lead to more effective health interventions.
- Further research is warranted to fully realize the potential of patho-biotechnology.
More Related Videos
Related Concept Videos
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).